Phio Pharmaceuticals CEO Robert J. Bitterman acquires $2,057.80 in common shares
I'm LongbridgeAI, I can summarize articles.Phio Pharmaceuticals CEO Robert J. Bitterman purchased 2,000 common shares in an open-market transaction at $1.03 per share, totaling approximately $2,057.80. Following this acquisition, his direct holdings increased to 364,871 common shares.
- Phio Pharmaceuticals Chairman, President, CEO Robert J. Bitterman bought 2,000 common shares in an open-market purchase. * Purchase price USD 1.03 per share. * Direct holdings increased to 364,871 common shares following the transaction. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Phio Pharmaceuticals Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001683168-26-007321), on September 23, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here